Fritextsökning
Innehållstyper
-
Charlotta Gummeson leaves Sahlgrenska Science Park – “It feels sad and exciting at the same time”
With mixed emotions, Charlotta Gummeson will leave her position as CEO of Sahlgrenska Science Park in October. “It feels sad and exciting at the same time. I’ve...
-
ZEISS presents the "Quality Innovation Summit"
A global event on the future of quality assurance.
-
CROs in drug development: "We use our expertise to speed up the process
Consultancy firms have become an increasingly important part of drug development. “It’s a trend and a business model that works, and we see no indication that i...
-
Julefrid ger läsetid – 10 artikeltips från redaktionen
När julstöket är avklarat, magen fått sitt och släkten avlägsnat sig lägger sig den stora friden – och kanske vaknar läslusten?
-
Sweden and Denmark – this is how they choose their strategies
Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.
-
Webinar: Clinical evaluation and clinical investigation of medical devices
Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
-
Anna Törner: You won’t find this many Concorde projects anywhere else
"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.
-
Biotechbolag får EU-miljoner för analys inom cellterapi
Bioteknikbolaget Neogap Therapeutics får fem miljoner kronor från EU-programmet Eurostars för utveckling av en analysmetod för T-cellsaktivitet mot tumörer.
-
Fast Optical Sectioning of Developing Organisms and Tissue Microstructures
ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.
-
The route to vaccines for everyone: “We did not just sit around and wait”
The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...
-
BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”
For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...
-
Ny miljonsatsning på life science i Sverige
7,7 miljoner kronor ska nu satsas på ett projekt för att underlätta identifiering och produktion av läkemedel. Bridge Sweden är namnet på projektet och är ett s...
-
Studie: Analys av 11 proteiner kunde förutsäga svår multipel skleros
Med hjälp av maskininlärning hittade forskare vid Linköpings universitet 11 proteiner som kunde förutsäga sjukdomsutvecklingen av multipel skleros.
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...
-
Helena Strigård: The rise of the community
Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.
-
Elicera develops CAR-T against solid tumours – may become the first in the world
Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...
-
Scanautomatic 8-10 oktober - Kom förbi med din utmaning, gå hem med en lösning!
Denna mässa får du inte missa! Vi kommer ha en monter på 90 kvm och visa upp vår bredd i sortimentet, vår kunskap och självklart vill vi snacka lösningar med di...
-
A billion-dollar acquisition makes Novo Nordisk even bigger in obesity
Danish pharmaceutical giant Novo Nordisk acquires Montreal-based Inversago Pharma, which develops treatments for obesity and diabetes.
-
Han är ny på AAX Biotech
Startup-bolaget AAX Biotech har rekryterat Juan Astorga-Wells till tjänsten som Senior Manager of Science & Development.
-
Norwegian company wins bidding battle for Sensidose
The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...
-
Göran Stiernstedt: “We are the world’s worst at continuity”
Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including...
BREAKING